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Primary effusion lymphoma (PEL) is an unusual and
rare type of non-Hodgkin’s lymphoma (NHL), and is
characterized by lymphomatous effusion of pleural,
pericardial or peritoneal cavities without lymphade-
nopathy or organomegaly [1,2]. It was documented
to be associated with human herpes virus-8 (HHV-8)
infection and most often occurs in immunocompro-
mised patients, particularly in patients with acquired
immunodeficiency syndrome (AIDS) [3]. Human
immunodeficiency virus (HIV)-negative, HHV-8 pos-
itive cases have been rarely reported, usually in areas
of high HHV-8 prevalence, such as the Mediterranean
region [3–8]. We recently encountered a patient with
PEL who was HHV-8 positive but HIV negative. In
this study, we present our experience for cytologic
diagnosis of PEL.
CASE PRESENTATION
A 69-year-old male patient had a history of oral cancer
(squamous cell carcinoma) treated by intra-arterial
chemotherapy 5 years previously, chronic renal dis-
ease, and mild fatty liver (HBsAg and anti-HCV neg-
ative). In July 2006, he presented with progressive
bilateral lower leg edema and distended abdomen
and he was hospitalized for further examination.
Chest X-ray revealed pleural effusion on the right
side and abdominal ultrasound revealed marked
ascites. Lymph node enlargement and organomegaly
were not observed. Hemogram revealed mild anemia
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Primary effusion lymphoma (PEL) is an unusual and rare type of non-Hodgkin’s lymphoma
characterized by lymphomatous effusion of pleural, pericardial or peritoneal cavities without
lymphadenopathy or organomegaly. It is associated with human herpes virus-8 (HHV-8) and
occurs most often in immunodeficient patients. We present a case of PEL in a 69-year-old male
presenting with pleural effusion and ascites. Fluid aspiration showed a monomorphic population
of atypical lymphoid cells, which were medium- to large-sized, with mono- or binucleated hyper-
chromatic nuclei and a small to moderate amount of basophilic cytoplasm containing cytoplasmic
vesicles. Immunohistochemically, the lymphoid cells expressed CD138 and multiple myeloma
oncogene 1, were positive for HHV-8, and were monoclonal for immunoglobulin heavy chain gene
rearrangement. They were negative for Epstein-Barr virus by in situ hybridization. Unfortunately,
the patient died during the first course of chemotherapy with cyclophosphamide, vincristine and
prednisone.
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(hemoglobin, 11.6 g/dL) with normal white blood
cell and platelet counts. His renal function was poor
with blood urea nitrogen (BUN) level of 75 mg/dL,
serum creatinine (Cr) level of 1.8 mg/dL, and creati-
nine clearance rate (Ccr) of 37.7 mL/minute. Blood
biochemistry was normal except for elevated lactic
dehydrogenase. His serum was negative for HIV and
human T lymphotropic viruses (HTLV) I/II using
enzyme-linked immunosorbent assay.
The tapped ascites had a turbid appearance.
Cytologic examination with Papanicolaou stain re-
vealed numerous atypical lymphoid cells of varying
morphology. Most of the tumor cells were medium-
to large-sized, some with plasmacytoid features and
cytoplasmic microvacuoles. The remaining sediment
was fixed in 10% buffered formalin, embedded in
paraffin, and processed using a routine cell block pro-
cedure. Microscopically, hematoxylin and eosin stain-
ing revealed a monomorphic population of atypical
lymphoid cells, which were medium- to large-sized,
and were single- or binucleated with hyperchromatic
nuclei. There was a small to moderate amount of
basophilic cytoplasm containing cytoplasmic vesicles
(Figure A). In addition, microorganisms were not
identified by acid-fast staining.
Immunohistochemical stains were performed on
4-μm-thick sections from a cell block prepared from
ascites. The majority of the atypical lymphoid cells
Figure. (A) Photomicrograph of a cell block section prepared from ascites shows medium- to large-sized tumor cells with single- or 
binucleated, hyperchromatic nuclei and a small to moderate amount of basophilic cytoplasm (hematoxylin & eosin). In situ hybridiza-
tion shows that the tumor cells were positive for: (B) CD138; and (C) human herpes virus-8 latency-associated nuclear antigen but not
for Epstein-Barr virus (data not shown). (D) Gel electrophoresis of the PCR product using primers for the framework III region of the
immunoglobulin heavy chain gene revealed single bands. Lane N = negative control; Lane M = 25-bp DNA size marker with an arrow
indicating the brightest band at 125 bp; Lane P = positive control (human Burkitt lymphoma cell line, BJAB); Lanes A1–A3 and
B1–B3 = triplicates using 1mL and 2mL of DNA sample for experiments, respectively.
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were positive for vimentin, CD30, CD138 (Figure B),
multiple myeloma oncogene 1 (MUM-1), and HHV-8
latency-associated nuclear antigen (Figure C), and neg-
ative for cytokeratin, calretinin, CD3, CD20, CD10,
CD45, CD79a, Bcl-2, Bcl-6, Pax-5, and latent membrane
protein 1 (LMP-1). In situ hybridization for Epstein-
Barr virus (EBV) was negative. A gene rearrangement
study using primers (Ig-FR3, ACA CGG C(C/T)(G/C)
TGT ATT ACT GT and Ig-LJH, TGA GGA GAC GGT
GAC C) directed against the framework III region of
immunoglobulin heavy chain (IgH) gene using poly-
merase chain reaction showed monoclonal results
(Figure D).
The patient received one cycle of COP (cyclophos-
phamide, vincristine and prednisone) chemotherapy,
but subsequently died due to neutropenic fever 3
months after diagnosis.
DISCUSSION
PEL was first reported in 1995, and was classified as 
a specific entity by the World Health Organization
Classification of Tumors in 1999 [3,9]. PEL is a neo-
plasm of large B-cells, and HHV-8 infection con-
stitutes the genetic hallmark of the disease, which
was assumed to be essential for PEL diagnosis. In
addition to infection by HHV-8/Kaposi’s sarcoma-
associated herpes virus, PEL is also frequently posi-
tive for EBV, particularly in AIDS-related cases,
whereas most PELs of HIV-negative hosts are EBV
negative [3]. However, the pathogenesis of PELs
remained unknown and is currently under active
investigation. The clinical, morphologic and molecu-
lar features of HIV-related and HIV-unrelated PELs
are similar, but PELs appear to occur at a substan-
tially older age in immunocompetent hosts than in
HIV-infected individuals [2,10].
PELs tend to present as serous effusions, usually
only affecting one area, without a contiguous solid
tumor mass. Rare cases involve more than one serous
cavity, which may result in PEL progression [11]. The
most common site of involvement is the pleural
space, but the peritoneal and pericardial cavity can
also be affected. Involvement of the gastrointestinal
tract, soft tissue and other extranodal sites has also
been reported [3,12–14].
Diagnosis of PEL is normally based on cytologic
evaluation of the fluid [15,16]. The morphology of the
affected fluid shows a variety of lymphoid cells,
which bridge the features of immunoblastic large cell
lymphoma and anaplastic large cell lymphoma. They
tend to be multinucleated or multilobulated large
cells with prominent nucleoli. The basophilic cyto-
plasm frequently contains small clear vacuoles. The
mitotic activity is usually high. Differential diagnosis
includes anaplastic large cell lymphoma, myeloma
and undifferentiated carcinoma.
Typically, PELs exhibit a non-B, non-T, indetermi-
nate immunophenotype, but they are positive for the
CD45, CD138/syndecan-1 and MUM-1 molecule,
which indicates that the lymphoma has an advanced
stage of B-cell differentiation, close to plasma cells
[17,18]. The expression of CD30, CD38, CD71, and
epithelial membrane antigen is associated with their
activation [19]. At the molecular level, clonal re-
arrangement of the IgH gene has been seen in the
majority of cases [20,21]. In addition, PEL is devoid of
the chromosomal translocations associated with other
aggressive B-cell NHLs, such as translocations of 
c-MYC, BCL-1, BCL-2 and BCL-6 [3,4,22,23].
The prognosis of malignant effusion lymphoma is
very poor, although chemotherapy such as high-dose
methotrexate combined with a CHOP (cyclophospha-
mide, doxorubicin, vincristine, prednisone)-derived
regimen has resulted in transient remissions [10,20,
24–26]. In previously published series, PEL patients
had a median survival of less than 6 months after
diagnosis [3,25]. The use of highly active antiretroviral
therapy has been suggested as a novel therapy for PEL
patients. The duration of remission can last several
months [26,27].
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以細胞學診斷人類免疫缺陷病毒陰性之
原發性積液淋巴瘤
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原發性積液淋巴瘤是一種罕見的非何杰金淋巴瘤。不同於其他淋巴瘤多以器官或淋巴
結腫大來表現，其特徵是含有淋巴瘤的體液在體腔內 (如腹腔、胸腔、心包膜腔 ) 異
常聚積，而患者多有 8 型人類皰疹病毒 (HHV-8) 感染相關或好發在免疫不全的人身
上。我們報告一位 69 歲男性以腹腔、胸腔積水作表現的原發性積液淋巴瘤的病例。
原發性積液淋巴瘤的細胞型態為單形性非典型性淋巴組織增生，具有中型到大型的單
核或雙核及少量到中量有空泡的嗜鹹性細胞質。免疫染色方面，這些非典型性淋巴球
表現 CD138、MUM1 及 HHV-8。並作 PCR 檢定其為單株細胞免疫蛋白重鏈基因重
組而原位雜交顯示為 Epstein-Barr 病毒陰性。不幸，此患者於確診後在接受第一次
化學治療的過程中死亡。
關鍵詞：8 型人類皰疹病毒，人類免疫缺陷病毒，原發性積液淋巴瘤
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